Sellas Life Sciences faces potential 12% share swing after upcoming earnings report

Small-cap biotech Sellas Life Sciences is bracing for a potentially significant market move of about 12% after its August 13 earnings release, with options market indicating heightened volatility amid ongoing pipeline uncertainties. SELLAS Life Sciences Group is heading into its…













